Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ROMIE LANE PEDIATRIC GROUP, INC

NPI: 1982601167 · SALINAS, CA 93901 · Specialist · NPI assigned 07/04/2005

$841K
Total Medicaid Paid
43,430
Total Claims
41,848
Beneficiaries
44
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialKOEHNE, WILLIAM (PRESIDENT)
NPI Enumeration Date07/04/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 4,833 $81K
2019 4,813 $78K
2020 4,994 $105K
2021 5,577 $112K
2022 7,478 $153K
2023 9,502 $189K
2024 6,233 $122K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
92551 5,192 5,177 $108K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1,293 1,289 $106K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 909 909 $95K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,141 2,061 $93K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,028 1,001 $72K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,016 989 $70K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,600 10,704 $54K
90686 2,307 2,295 $40K
G9920 Screening performed and negative 1,394 1,378 $39K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 526 498 $35K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,920 4,618 $30K
99173 4,329 4,315 $27K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 293 281 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 230 223 $6K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 569 568 $6K
87634 104 104 $6K
G0442 Annual alcohol misuse screening, 5 to 15 minutes 229 229 $5K
90670 286 276 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 475 445 $4K
0071A 88 88 $4K
0072A 84 84 $3K
85018 1,632 1,597 $3K
90698 198 190 $3K
0002A 70 70 $3K
90651 128 128 $2K
90680 113 110 $2K
90656 97 97 $2K
96110 Developmental screening, with scoring and documentation, per standardized instrument 76 71 $1K
0001A 36 36 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,115 1,078 $1K
96127 171 169 $1K
81003 513 507 $897.57
90480 13 13 $520.00
0004A 13 13 $520.00
90744 35 33 $504.00
99188 12 12 $324.00
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 34 33 $305.45
90621 15 15 $252.00
83655 24 24 $223.23
90619 12 12 $216.00
90685 12 12 $216.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 26 26 $181.67
G2010 Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment 25 24 $0.00
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 47 46 $0.00